Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentamidine plus tamoxifen versus pentamidine alone for cutaneous leishmaniasis
RBR-7y2gbdfPhase 2Completed
- Sponsor
- Silmara Navarro Pennini
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in cutaneous leishmaniasis (CL) comparing pentamidine + tamoxifen with Control: pentamidine (2 arms). Started Oct 2020; status: completed.
02
Drugs
pentamidinetamoxifen
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on RBR-7y2gbdf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7y2gbdf.